» Articles » PMID: 1363131

The Effect of CGP 37849 and CGP 39551, Competitive NMDA Receptor Antagonists, in the Forced Swimming Test

Overview
Specialties Pharmacology
Pharmacy
Date 1992 Jul 1
PMID 1363131
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The present study examined the effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test in rats and mice. Administered in a single dose or three times both examined compounds reduced the immobility time in rats. Active doses used in that test either did not change the locomotor activity or decreased it. A similar effect in both tests was shown by active (R)-enantiomers CGP 40116 and CGP 43487. Reduction of the immobility time induced by CGP 37849 and CGP 39551 in the forced swimming test in rats was antagonized by haloperidol and (+/-)-sulpiride, but not by SCH 23390 or prazosin. CGP 37849, but not CGP 39551, also reduced the immobility time in the forced swimming test in mice. The results obtained indicate that CGP 37849 and CGP 39551 induce an antidepressant-like effect in the forced swimming test, probably via an indirect dopamine activation resulting from blockade of NMDA receptors.

Citing Articles

Dopamine, activation of ingestion and evaluation of response efficacy: a focus on the within-session time-course of licking burst number.

DAquila P Psychopharmacology (Berl). 2024; 241(6):1111-1124.

PMID: 38702473 PMC: 11106101. DOI: 10.1007/s00213-024-06600-1.


Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder.

Almeida R, Ferreira T, David C, Abreu E Silva P, Dos Santos S, Rodrigues A Front Pharmacol. 2021; 12:652130.

PMID: 33927625 PMC: 8076783. DOI: 10.3389/fphar.2021.652130.


Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice.

Stasiuk W, Szopa A, Serefko A, Wyska E, Swiader K, Dudka J J Neural Transm (Vienna). 2016; 124(3):387-396.

PMID: 27900470 PMC: 5310560. DOI: 10.1007/s00702-016-1657-8.


Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies.

Carvajal F, Mattison H, Cerpa W Neural Plast. 2016; 2016:2701526.

PMID: 27630777 PMC: 5007376. DOI: 10.1155/2016/2701526.


Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice.

Poleszak E, Stasiuk W, Szopa A, Wyska E, Serefko A, Oniszczuk A Metab Brain Dis. 2016; 31(4):803-14.

PMID: 26924124 PMC: 4933725. DOI: 10.1007/s11011-016-9810-5.